An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer

Table 3

Multivariate analyses of OS among cervical cancer patients based on clinicopathological features and immune scores.

Characteristics	OS
	HR (95% CI)	value
Age (y)^a
≤40	1.000
40-50	1.285 (0.549,3.006)	0.563
50-60	0.931 (0.327, 2.653)	0.894
60-70	1.079 (0.375, 3.103)	0.888
70-80	5.722 (1.666, 19.647)	0.006
>80	-	0.998
Immune scores
≤374.3	1.000
374.3 to 1051.6	0.864 (0.412, 1.811)	0.699
>1051.6	0.305 (0.108, 0.869)	0.026
Stage
I	1.000
II	1.418 (0.584, 3.445)	0.441
III	1.249 (0.357, 4.364)	0.728
IV	5.898 (2.404, 14.473)	0.0001

Abbreviations: CI: confidence interval; ^aAge at diagnosis of cervical cancer.